FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Olsen

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Physiology

Vascular Resistance

Anatomy

Heart Ventricles

Co-author Network

Publications

TOP 3
Marina De Marco; Kurt Boman; Giuseppina Casalnuovo; Björn Dahlöf; Richard B Devereux; Eva Gerdts; Jorge R Kizer; Teresa Migliore; Michael H Olsen; Kristian Wachtell; Giovanni de Simone
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study.
Julie K K Vishram; Anne H Andreasen; Anders Borglykke; Grazyna Broda; Giancarlo Cesana; Chiara Donfrancesco; Simona Giampaoli; Hans Ibsen; Jørgen Jeppesen; Torben Jørgensen; Frank Kee; Kari Kuulasmaa; Giuseppe Mancia; Michael H Olsen; Luigi Palmieri; Susana Sans
Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project.
Thomas Sehestedt; Christian Torp-Pedersen; Kristian Wachtell; Susanne Rasmussen; Tine W Hansen; Hans Ibsen; Jørgen Jeppesen; Michael H Olsen
Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Olsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marina De Marco; Kurt Boman; Giuseppina Casalnuovo; Björn Dahlöf; Richard B Devereux; Eva Gerdts; Jorge R Kizer; Teresa Migliore; Michael H Olsen; Kristian Wachtell; Giovanni de Simone
Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: the LIFE study.
American journal of hypertension 2013;26(4):567-73.
2012: Julie K K Vishram; Anne H Andreasen; Anders Borglykke; Grazyna Broda; Giancarlo Cesana; Chiara Donfrancesco; Simona Giampaoli; Hans Ibsen; Jørgen Jeppesen; Torben Jørgensen; Frank Kee; Kari Kuulasmaa; Giuseppe Mancia; Michael H Olsen; Luigi Palmieri; Susana Sans
Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project.
Hypertension 2012;60(5):1117-23.
2012: Thomas Sehestedt; Christian Torp-Pedersen; Kristian Wachtell; Susanne Rasmussen; Tine W Hansen; Hans Ibsen; Jørgen Jeppesen; Michael H Olsen
Thresholds for pulse wave velocity, urine albumin creatinine ratio and left ventricular mass index using SCORE, Framingham and ESH/ESC risk charts.
Journal of hypertension 2012;30(10):1928-36.
2012: Anne Cecilie K Larstorp; Peter M Okin; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Kristian Wachtell
Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study.
American journal of hypertension 2012;25(10):1101-9.
2012: Anders M Greve; Mai T Lønnebakken; Markku S Nieminen; Peter M Okin; Michael H Olsen; Per Omvik; Vittorio Palmieri; Jonathan Bella; Kurt Boman; Björn Dahlöf; Richard B Devereux; Eva Gerdts; Kristian Wachtell
Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: a LIFE study.
American journal of hypertension 2012;25(9):1017-23.
2012: Anne Cecilie K Larstorp; Peter M Okin; Michael H Olsen; Inger Ariansen; Björn Dahlöf; Richard B Devereux; Knut Gjesdal; Hans Ibsen; Sverre E Kjeldsen; Kristian Wachtell
Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.
Hypertension 2012;60(2):347-53.
2012: Anne Christine H Ruwald; Thomas Sehestedt; Kristian Wachtell; Bo Westergaard; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Michael H Olsen
Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Journal of hypertension 2012;30(6):1252-9.
2012: Thomas Sehestedt; Christian Torp-Pedersen; Kristian Wachtell; Susanne Rasmussen; Tine W Hansen; Hans Ibsen; Jørgen Jeppesen; Michael H Olsen
Can ambulatory blood pressure measurements substitute assessment of subclinical cardiovascular damage?
Journal of hypertension 2012;30(3):513-21.
2012: Inger Ariansen; Björn Dahlöf; Richard B Devereux; Knut Gjesdal; Hans Ibsen; Sverre E Kjeldsen; Peter M Okin; Michael H Olsen; Henrik M Reims; Kristian Wachtell
Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study.
Blood pressure 2012;21(1):6-11.
2011: Josep Redon; Michael H Olsen; Richard S Cooper; Oscar Zurriaga; Miguel A Martinez-Beneito; Stephane Laurent; Renata Cifkova; Antonio Coca; Guiseppe Mancia
Stroke mortality and trends from 1990 to 2006 in 39 countries from Europe and Central Asia: implications for control of high blood pressure.
European heart journal 2011;32(11):1424-31.
2010: Michael H Olsen; Jean-Michel Mallion; Karl-Heinz Rahn; Serap Erdine; Margus Viigimaa; Stéphane Laurent; Enrico Agabiti-Rosei; Giuseppe Mancia; Roland E Schmieder; Renata Cifkova; Anna Dominiczak; Sverre E Kjeldsen; Josep Redon; Alberto Zanchetti; Peter Nilsson; Krzysztof Narkiewicz
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire.
Journal of hypertension 2010;28(7):1593-4.
2010: Kristian Wachtell; Eva Gerdts; Gerard P Aurigemma; Kurt Boman; Björn Dahlöf; Markku S Nieminen; Michael H Olsen; Peter M Okin; Vittorio Palmieri; Jens E Rokkedal; Richard B Devereux
In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
Blood pressure 2010;19(3):169-75.
2010: Thomas Sehestedt; Michael H Olsen
Subclinical organ damage and cardiovascular risk prediction.
Blood pressure 2010;19(3):132-9.
2010: Thomas Sehestedt; Jørgen Jeppesen; Tine W Hansen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Christian Torp-Petersen; Per Hildebrandt; Michael H Olsen
Risk prediction is improved by adding markers of subclinical organ damage to SCORE.
European heart journal 2010;31(7):883-91.
2009: Michael H Olsen; Kristian Wachtell; Gareth Beevers; Björn Dahlöf; Giovanni de Simone; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Paulette A Lyle; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2009;27(3):567-74.
2008: Michael H Olsen; T W Hansen; M K Christensen; F Gustafsson; S Rasmussen; Kristian Wachtell; Hans Ibsen; C Torp-Pedersen; Per Hildebrandt
Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.
Journal of human hypertension 2008;22(9):634-40.
2008: Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Per R Hildebrandt
Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
Journal of hypertension 2008;26(1):26-34.
2007: Marianne L Smebye; Emil K Iversen; Aud Høieggen; Arnljot Flaa; Ingrid Os; Sverre E Kjeldsen; Michael H Olsen; Arghya Chattopadhyay; Darcy A Hille; Paulette A Lyle; Richard B Devereux; Björn Dahlöf
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study).
The American journal of cardiology 2007;100(5):855-9.
2007: Kristian Wachtell; Peter M Okin; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Kristian Thygesen
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
Circulation 2007;116(7):700-5.
2007: Giovanni de Simone; Michael H Olsen; Kristian Wachtell; Darcy A Hille; Björn Dahlöf; Hans Ibsen; Sverre E Kjeldsen; Paulette A Lyle; Richard B Devereux
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
Journal of human hypertension 2007;21(8):625-32.
2007: Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Hans Ibsen; Christian Torp-Pedersen; Per R Hildebrandt
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population.
European heart journal 2007;28(11):1374-81.
2007: Wouter B A Eijkelkamp; Zhongxin Zhang; Barry M Brenner; Mark E Cooper; Richard B Devereux; Björn Dahlöf; Hans Ibsen; William F Keane; Lars H Lindholm; Michael H Olsen; Hans-Henrik Parving; Giuseppe Remuzzi; Shahnaz Shahinfar; Steven M Snapinn; Kristian Wachtell; Dick De Zeeuw
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studies.
Journal of hypertension 2007;25(4):871-6.
2007: Lia E Bang; Niels Wiinberg; Kristian Wachtell; John Larsen; Michael H Olsen; Christian Tuxen; Per R Hildebrandt; Hans Ibsen
Losartan versus atenolol on 24-hour ambulatory blood pressure. A LIFE substudy.
Blood pressure 2007;16(6):392-7.
2006: Michael H Olsen; Kristian Wachtell; Olav Wendelboe Nielsen; Christian Hall; Ragnhild Wergeland; Hans Ibsen; Sverre E Kjeldsen; Richard B Devereux; Björn Dahlöf; Per R Hildebrandt
N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Journal of hypertension 2006;24(8):1531-9.
2006: Michael H Olsen; Kristian Wachtell; Björn Dahlöf; R B Devereux; Hans Ibsen; S E Kjeldsen; Lars H Lindholm; Paulette A Lyle; Markku S Nieminen
The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
Journal of human hypertension 2006;20(6):460-4.
2006: Michael H Olsen; Marina K Christensen; Tine W Hansen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Knut Borch-Johnsen; Hans Ibsen; Torben Jørgensen; Per Hildebrandt
High-sensitivity C-reactive protein is only weakly related to cardiovascular damage after adjustment for traditional cardiovascular risk factors.
Journal of hypertension 2006;24(4):655-61.
2006: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Sverre E Kjeldsen; Hans Ibsen; Ying Wan; Stevo Julius
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(3):169-73.
2006: Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl E Mogensen; Björn Dahlöf; Steven M Snapinn; Ying Wan; Paulette A Lyle
Does albuminuria predict cardiovascular outcomes on treatment with losartan versus atenolol in patients with diabetes, hypertension, and left ventricular hypertrophy? The LIFE study.
Diabetes care 2006;29(3):595-600.
2006: Marina K Christensen; Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Niels Wiinberg; Richard B Devereux; Sverre E Kjeldsen; Per Hildebrandt; Jens Rokkedal; Hans Ibsen
Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy.
Blood pressure 2006;15(4):198-206.
2005: Andreas Kjaer; Christian Meyer; Kristian Wachtell; Michael H Olsen; Hans Ibsen; Lionel Opie; Søren Holm; Birger Hesse
Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy.
The American journal of cardiology 2005;96(12):1692-8.
2005: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Vittorio Palmieri; Eva Gerdts; Gunnar Smith; Markku S Nieminen; Björn Dahlöf; Hans Ibsen; Richard B Devereux
Aortic valve sclerosis and albuminuria predict cardiovascular events independently in hypertension: a losartan intervention for endpoint-reduction in hypertension (LIFE) substudy.
American journal of hypertension 2005;18(11):1430-6.
2005: Michael H Olsen; Tine W Hansen; Marina K Christensen; Finn Gustafsson; Susanne Rasmussen; Kristian Wachtell; Knut Borch-Johnsen; Hans Ibsen; Torben Jørgensen; Per Hildebrandt
N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
Hypertension 2005;46(4):660-6.
2005: Stanley S Franklin; Kristian Wachtell; Vasilios Papademetriou; Michael H Olsen; Richard B Devereux; Frej Fyhrquist; Hans Ibsen; Sverre E Kjeldsen; Björn Dahlöf
Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy.
Hypertension 2005;46(3):492-9.
2005: Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Christian Hall; Hans Ibsen; Jens Rokkedal; Richard B Devereux; Per R Hildebrandt
Opposite effects of losartan and atenolol on natriuretic peptides in patients with hypertension and left ventricular hypertrophy: a LIFE substudy.
Journal of hypertension 2005;23(5):1083-90.
2005: Michael H Olsen; Eigil Fossum; Aud Høieggen; Kristian Wachtell; Elsa Hjerkinn; Shawna D Nesbitt; Ulrik B Andersen; Robert A Phillips; Cynthia L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy.
Journal of hypertension 2005;23(4):891-8.
2005: Michael H Olsen; Marina K Christensen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Niels Wiinberg; Richard B Devereux; Sverre E Kjeldsen; Per Hildebrandt; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.
Journal of human hypertension 2005;19(4):301-7.
2005: Kristian Wachtell; Mika Lehto; Eva Gerdts; Michael H Olsen; Björn Hornestam; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Richard B Devereux
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):712-9.
2005: Kristian Wachtell; Björn Hornestam; Mika Lehto; David Slotwiner; Eva Gerdts; Michael H Olsen; Peter Aurup; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Jens Rokkedal; Richard B Devereux
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):705-11.
2005: Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Hypertension 2005;45(2):198-202.
2005: Michael H Olsen; Kristian Wachtell; Keld Neland; Jonathan Bella; Jens Rokkedal; Harriet Dige-Petersen; Hans Ibsen
Losartan but not atenolol reduce carotid artery hypertrophy in essential hypertension. A LIFE substudy.
Blood pressure 2005;14(3):177-83.
2005: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Eva Gerdts; Vittorio Palmieri; Markku S Nieminen; Gunnar Smith; Hans Ibsen; Richard B Devereux
Aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy).
The American journal of cardiology 2005;95(1):132-6.
2004: Hans Ibsen; Kristian Wachtell; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE Study.
Kidney international. Supplement 2004;(92):S56-8.
2004: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Jennifer E Liu; Kurt Boman; Eva Gerdts; Vasilios Papademetriou; Markku S Nieminen; Jens Rokkedal; Björn Dahlöf; Richard B Devereux
Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy).
The American journal of cardiology 2004;94(8):1076-80.
2004: Hans Ibsen; Kristian Wachtell; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
Journal of hypertension 2004;22(9):1805-11.
2004: Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Christian Hall; Hans Ibsen; Jens Rokkedal; Richard B Devereux; Per Hildebrandt
N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study.
Journal of hypertension 2004;22(8):1597-604.
2004: Michael H Olsen; Kristian Wachtell; Jonathan Bella; Vittorio Palmieri; Eva Gerdts; G Smith; Markku S Nieminen; B Dahlöf; Hans Ibsen; Richard B Devereux
Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy.
Journal of human hypertension 2004;18(6):453-9.
2004: Niels Wiinberg; Lia E Bang; Kristian Wachtell; J Larsen; Michael H Olsen; Christian Tuxen; Per R Hildebrandt; Jens Rokkedal; Hans Ibsen; Richard B Devereux
24-h Ambulatory blood pressure in patients with ECG-determined left ventricular hypertrophy: left ventricular geometry and urinary albumin excretion-a LIFE substudy.
Journal of human hypertension 2004;18(6):391-6.
2004: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen
Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy.
Journal of human hypertension 2004;18(6):375-80.
2004: Michael H Olsen; Kristian Wachtell; G de Simone; Vittorio Palmieri; Harriet Dige-Petersen; Richard B Devereux; Hans Ibsen; Jens Rokkedal
Is inappropriate left ventricular mass related to neurohormonal factors and/or arterial changes in hypertension? A LIFE substudy.
Journal of human hypertension 2004;18(6):437-43.
2004: Michael H Olsen; Kristian Wachtell; Christian Meyer; Jens D Hove; Vittorio Palmieri; Harriet Dige-Petersen; Jens Rokkedal; Birger Hesse; Hans Ibsen
Association between vascular dysfunction and reduced myocardial flow reserve in patients with hypertension: a LIFE substudy.
Journal of human hypertension 2004;18(6):445-52.
2003: Kristian Wachtell; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Peter M Okin; Per Omvik; Suzanne Oparil; Hans Wedel; Steven M Snapinn; Peter Aurup
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Annals of internal medicine 2003;139(11):901-6.
2003: Lars H Lindholm; Björn Dahlöf; Jonathan Edelman; Hans Ibsen; Knut Borch-Johnsen; Michael H Olsen; Steven M Snapinn; Kristian Wachtell
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study.
Lancet 2003;362(9384):619-20.
2003: Michael H Olsen; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Jonathan Bella; Shawna D Nesbitt; Eigil Fossum; Sverre E Kjeldsen; Stevo Julius; Hans Ibsen
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy.
Journal of human hypertension 2003;17(5):305-11.
2003: Ulrik B Andersen; Michael H Olsen; Harriet Dige-Petersen; Hans Ibsen
Exercise blood pressure is related to insulin resistance in subjects with two hypertensive parents.
Blood pressure 2003;12(5-6):314-8.
2002: Michael H Olsen; Kristian Wachtell; Kristine L Hermann; Erik Frandsen; Harriet Dige-Petersen; Jens Rokkedal; Richard B Devereux; Hans Ibsen
Is cardiovascular remodeling in patients with essential hypertension related to more than high blood pressure? A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
American heart journal 2002;144(3):530-7.
2002: Lars H Lindholm; Hans Ibsen; Knut Borch-Johnsen; Michael H Olsen; Kristian Wachtell; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2002;20(9):1879-86.
2002: Kristian Wachtell; Vittorio Palmieri; Michael H Olsen; Eva Gerdts; Vasilios Papademetriou; Markku S Nieminen; Gunnar Smith; Björn Dahlöf; Gerard P Aurigemma; Richard B Devereux
Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study.
Circulation 2002;106(2):227-32.
2002: Michael H Olsen; Kristian Wachtell; Christian Aalkjaer; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Vasodilatory capacity and vascular structure in long-standing hypertension: a LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
American journal of hypertension 2002;15(5):398-404.
2002: Kristian Wachtell; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Markku S Nieminen; Peter M Okin; Vasilios Papademetriou; Carl E Mogensen; Knut Borch-Johnsen; Hans Ibsen
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2002;20(3):405-12.
2002: Kristian Wachtell; Vittorio Palmieri; Michael H Olsen; Jonathan Bella; Tapio Aalto; Björn Dahlöf; Eva Gerdts; Jackson T Wright; Vasilios Papademetriou; Carl E Mogensen; Knut Borch-Johnsen; Hans Ibsen; Richard B Devereux
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction.
American heart journal 2002;143(2):319-26.
2002: Jonathan Bella; Kristian Wachtell; Kurt Boman; Vittorio Palmieri; Vasilios Papademetriou; Eva Gerdts; Tapio Aalto; Michael H Olsen; Mona Olofsson; Björn Dahlöf; Mary J Roman; Richard B Devereux
Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study).
The American journal of cardiology 2002;89(3):337-41.
2002: Michael H Olsen; Kristian Wachtell; Kristine L Hermann; Jonathan Bella; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Left ventricular hypertrophy is associated with reduced vasodilatory capacity in the brachial artery in patients with longstanding hypertension. A LIFE substudy.
Blood pressure 2002;11(5):285-92.
2001: Michael H Olsen; Kristian Wachtell; Kristine L Hermann; Jonathan Bella; Ulrik B Andersen; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Maximal exercise capacity is related to cardiovascular structure in patients with longstanding hypertension. A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
American journal of hypertension 2001;14(12):1205-10.
2001: Michael H Olsen; Kristian Wachtell; Christian Aalkjaer; Richard B Devereux; Harriet Dige-Petersen; Hans Ibsen
Endothelial dysfunction in resistance arteries is related to high blood pressure and circulating low density lipoproteins in previously treated hypertension.
American journal of hypertension 2001;14(9 Pt 1):861-7.
2000: Michael H Olsen; Ulrik B Andersen; Kristian Wachtell; Hans Ibsen; Harriet Dige-Petersen
A possible link between endothelial dysfunction and insulin resistance in hypertension. A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension.
Blood pressure 2000;9(2-3):132-9.
2000: Michael H Olsen; Eigil Fossum; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Shawna D Nesbitt; Ulrik B Andersen; R A Phillips; C L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia.
Journal of hypertension 2000;18(1):75-81.
1999: Michael H Olsen; Ulrik B Andersen; Kristian Wachtell; Hans Ibsen; Harriet Dige-Petersen
Influence of non-steady state during isoglycemic hyperinsulinemic clamp in hypertension. A LIFE substudy.
Blood pressure 1999;8(4):207-13.